Data thru May 13, 2026
HomeTrendsArticlesDrug MarketsTherapeutic ClassesManufacturersPricingContact
Back to Market Feed

PREGABALIN 300 MG CAPSULE

Pregabalin
$0.0669per EA
DEA Schedule CV

Strength

300 mg/1

Manufacturer

Sun Pharmaceutical Industries Inc.

NDC

47335069388

Classification

Generic

Dosage Form

CAPSULE

Route

ORAL

Last Updated

2/18/2026

Active Ingredients

PREGABALIN

Approval Type

Generic (ANDA)

FDA Application

ANDA091157

On Market Since

12/4/2019

Price History

1W

0.0%

1M

0.0%

3M

-0.6%

6M

-6.3%

1Y

-16.6%

3Y

-37.9%

5Y

-54.9%

All

-65.9%

Generic Alternatives

Save up to 1%

9 alternatives • Same active ingredient

PREGABALIN 300 MG CAPSULE
Generic
69367033109•Westminster Pharmaceuticals LLC
$0.0660
Save 1%
PREGABALIN 300 MG CAPSULE
Generic
69238131709•Amneal Pharmaceuticals NY LLC
$0.0660
Save 1%
PREGABALIN 300 MG CAPSULE
Generic
67877046990•Ascend Laboratories, LLC
$0.0660
Save 1%
PREGABALIN 300 MG CAPSULE
Generic
65862076590•Aurobindo Pharma Limited
$0.0660
Save 1%
PREGABALIN 300 MG CAPSULE
Generic
31722061705•Camber Pharmaceuticals Inc.
$0.0660
Save 1%
PREGABALIN 300 MG CAPSULE
Generic
72205001890•Novadoz Pharmaceuticals LLC
$0.0660
Save 1%
PREGABALIN 300 MG CAPSULE
Generic
13668036505•Torrent Pharmaceuticals Limited
$0.0660
Save 1%
PREGABALIN 300 MG CAPSULE
Generic
62332012690•Alembic Pharmaceuticals Inc.
$0.0660
Save 1%
PREGABALIN 300 MG CAPSULE
Generic
27808024101•Tris Pharma Inc
$0.0772
+15% more

Related Drugs

Same classification

No related drugs found.

Data Source

Pricing data sourced from the National Average Drug Acquisition Cost (NADAC) survey, published by the Centers for Medicare & Medicaid Services (CMS). Updated weekly.

Disclaimer

This site is for informational purposes only and does not constitute medical, pharmaceutical, or financial advice. NADAC prices are survey-based estimates and may not reflect actual acquisition costs at any specific pharmacy.

Navigate

HomeAboutManufacturersDrug MarketsTherapeutic ClassesTrendsArticlesPricingContact

© 2026 NADAC Intelligence. All rights reserved. Not affiliated with CMS or any government agency.

Terms of ServicePrivacy Policy